Authors' response

Affiliations

¹ Department of Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi 110 029, India.
² Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi 110 029, India.
³ Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi 110 029, India.
⁴ Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi 110 029, India.

Comment

Ritu Gupta et al. Indian J Med Res. 2021 May.

. 2021 May;153(5&6):565-567.

doi: 10.4103/0971-5916.323967.

¹ Department of Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi 110 029, India.
² Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi 110 029, India.
³ Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi 110 029, India.
⁴ Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi 110 029, India.

No abstract available

Conflict of interest statement

None

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R, Dwivedi T, Gajendra S, Sahoo B, Gupta SK, Vikas H, Singh AR, Mohan A, Bhatnagar S, Singh S, Wundavalli L, Guleria R. Gupta R, et al. Indian J Med Res. 2021 Jan & Feb;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20. Indian J Med Res. 2021. PMID: 33642348 Free PMC article.
Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection.
Yadav RM, Madkaikar MR. Yadav RM, et al. Indian J Med Res. 2021 May;153(5&6):564-565. doi: 10.4103/ijmr.ijmr_1092_21. Indian J Med Res. 2021. PMID: 34414921 Free PMC article. No abstract available.

1. Yadav RM, Pate A, Shankarkumar A, Athalye S, Shinde S, Bargir UA, et al. Serosurvey for health-care workers provides supportive evidence for the effectiveness of hydroxychloroquine prophylaxis against SARS-CoV-2 infection. J Epidemiol Glob Health. 2021 doi: 10.2991/gegh.k.210518.001. - PMC - PubMed
1. Gupta R, Dwivedi T, Gajendra S, Sahoo B, Gupta SK, Vikas H, et al. Seroprevalence of antibodies to SARS- CoV-2 in healthcare workers & implications of infection control practice in India. Indian J Med Res. 2021;153:207–13. - PMC - PubMed
1. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, et al. Health care workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian J Med Res. 2020;151:459–67. - PMC - PubMed
1. Goenka M, Afzalpurkar S, Goenka U, Das SS, Mukherjee M, Jajodia S, et al. Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India. J Assoc Physicians India. 2020;68:14–9. - PubMed
1. Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, et al. Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: A randomized trial. Clin Infect Dis. 2021;72:e835–43. - PMC - PubMed